Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes.

Athena Philis-Tsimikas,Harpreet S Bajaj,Kamilla Begtrup,Roman Cailleteau,Amoolya Gowda,Ildiko Lingvay,Chantal Mathieu,David Russell-Jones,Julio Rosenstock

Diabetes, obesity & metabolism（2023）

引用 8|浏览28

暂无评分

摘要

The ONWARDS 1-6 trials will evaluate the efficacy and safety of once-weekly icodec compared with currently available daily basal insulin analogues in T2D and T1D. These trials will generate comprehensive evidence of icodec use in diverse populations across the spectrum of diabetes progression and treatment experience.

查看译文

关键词

basal insulin,phase III study,type 1 diabetes,type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要